Schneider L H, Alpert J E, Iversen S D
Peptides. 1983 Sep-Oct;4(5):749-53. doi: 10.1016/0196-9781(83)90031-1.
Rats (N = 15) were implanted with cannulae above the dopaminergic A10 ventral tegmental area (VTA). Two weeks later, four measures of open field behavior were quantified for 10 minutes commencing 30 minutes after parenteral d-amphetamine (1.5 mg/kg) and directly after bilateral infusion of 1.5 microliter of: (a) artificial CSF only (VEH), (b) 1.25 microgram desulfated CCK (DS-CCK), or (c) 1.25 microgram sulfated CCK (CCK). Additional rats with bilateral cannulae directed toward the A10 terminal zones of nucleus accumbens were similarly tested with either VEH (N = 2) or sulfated CCK (N = 2). With VTA infusions, both the number of occurrences and duration of rearing were significantly reduced in CCK rats, while neither the number of square crossings nor duration of forward locomotion were significantly modified from controls. With nuclei accumbens septi (NAS) infusions, CCK-8 reduced rearing behavior more than ambulatory behavior in this preliminary testing. With either VTA or NAS infusions, no significant differences from controls were found upon two derived measures of motoric performance, namely, "velocity" (number of squares crossed per second in locomotion) and "vertical stability" (seconds per rear). These results suggest a modulation of dopaminergically-mediated behavior by (sulfated) CCK-8 at the cell body region and terminal fields of the mesolimbic (A10) dopamine system.
将15只大鼠在多巴胺能A10腹侧被盖区(VTA)上方植入套管。两周后,在腹腔注射d-苯丙胺(1.5mg/kg)30分钟后开始,并在双侧注入1.5微升以下物质后立即对10分钟内的四项旷场行为指标进行量化:(a)仅注入人工脑脊液(VEH),(b)1.25微克去硫酸化胆囊收缩素(DS-CCK),或(c)1.25微克硫酸化胆囊收缩素(CCK)。另外,将双侧套管指向伏隔核A10终末区的大鼠同样用VEH(n = 2)或硫酸化CCK(n = 2)进行测试。对于VTA注入,CCK组大鼠的站立次数和持续时间均显著减少,而穿越方格的次数和向前运动的持续时间与对照组相比均无显著改变。在伏隔核注入时,在这项初步测试中,CCK-8对站立行为的减少作用大于对行走行为的减少作用。对于VTA或伏隔核注入,在两项运动性能衍生指标,即“速度”(运动中每秒穿越的方格数)和“垂直稳定性”(每次站立的秒数)方面,与对照组均未发现显著差异。这些结果表明,(硫酸化)CCK-8在中脑边缘(A10)多巴胺系统的细胞体区域和终末场对多巴胺介导的行为具有调节作用。